Dashboard
Manage Tickers

RENB


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
Lunai Bioworks Adopts New Corporate Identi...
09/30/2025 13:43:43

Lunai Bioworks Inc. (NASDAQ:LNAI), a pioneer in AI-powered drug discovery and biodefense, today announced the formal adoption o...

trading-halt-halt-status-updated-at-85500-am-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 8:55:...
09/30/2025 12:55:04

trading-halt-halted-at-75000-pm-et---trading-halt-halt-news-pending
Trading Halt: Halted at 7:50:00 p.m. ET - ...
09/29/2025 23:50:04

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
09/25/2025 17:06:09

Gainers PepGen (NASDAQ: PEPG) stock rose 114.3% to $5.7 during Thursday's regular session. The market value of their outst...

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
09/25/2025 12:08:49

Gainers PepGen (NASDAQ: PEPG) shares rose 141.0% to $6.41 during Thursday's pre-market session. The market value of their ...

why-pepgen-shares-are-trading-higher-by-112-here-are-20-stocks-moving-premarket
Why PepGen Shares Are Trading Higher By 11...
09/25/2025 10:11:08

Shares of PepGen Inc. (NASDAQ: PEPG) rose sharply in pre-market trading after the company announced the launch of an underwritt...

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
09/24/2025 21:06:04

lunai-bioworks-announces-10-for-1-reverse-stock-split-effective-september-30-2025
Lunai Bioworks Announces 10-For-1 Reverse ...
09/24/2025 20:51:41

Measure taken to Comply with Nasdaq Rule 5550(a)(2) Regarding Minimum Bid PriceLOS ANGELES, CA / ACCESS Newswire / September 24...

lunai-bioworks-subsidiary-biosymetrics-wins-185m-nih-grant-to-advance-ai-powered-alcohol-use-disorder-drug-discovery
Lunai Bioworks Subsidiary BioSymetrics Win...
09/11/2025 11:07:23

Lunai Bioworks Inc.'s (NASDAQ:RENB) wholly-owned subsidiary BioSymetrics Inc. today announced the award of a prestigious Sm...

top-3-health-care-stocks-youll-regret-missing-in-q3
Top 3 Health Care Stocks You'll Regret Mis...
09/09/2025 13:12:17

lunai-bioworks-launches-ai-platform-embedding-biological-risk-intelligence-to-accelerate-drug-discovery-and-enhance-biodefense-against-ai-designed-toxins
Lunai Bioworks Launches AI Platform Embedd...
09/09/2025 12:48:45

Proprietary safety intelligence creates dual value: faster therapeutic development and biodefense.LOS ANGELES, CALIFORNIA / ACC...

lunai-bioworks-reaffirms-long-term-commitment-to-european-markets-and-partnerships-amid-bankruptcy-of-subsidiary-gedi-cube
Lunai Bioworks Reaffirms Long-Term Commitm...
09/08/2025 12:53:02

unai Bioworks Inc. (NASDAQ:RENB), an AI-powered drug discovery and biodefense company, today reaffirmed its long-term commitmen...

lunai-bioworks-dba-renovaro-partners-with-american-defense-international-to-advance-ai-powered-countermeasures-against-chemical-and-biological-threats-including-highly-toxic-agents-such-as-sarin-nerve-gas
Lunai Bioworks DBA Renovaro Partners With ...
09/04/2025 14:09:48

Collaboration aims to apply Lunai Bioworks Inc. biomedical AI platform to accelerate countermeasure development for chemical ag...

renovaro-to-change-its-corporate-name-to-lunai-bioworks-inc-reflecting-strategic-direction-in-ai-powered-biodefense-drug-discovery-and-advanced-diagnostics
Renovaro To Change Its Corporate Name To L...
08/27/2025 13:47:47

Renovaro Inc. (NASDAQ:RENB) today announced that it will change its corporate name to Lunai Bioworks, Inc. to better reflect it...

renovaro-multiple-us-patent-allowances-to-bolster-biomedical-ai-platform-including-application-no-18058732-for-unbiased-drug-discovery-predictions
Renovaro Multiple U.S. Patent Allowances T...
07/28/2025 14:41:28

Strategic IP expansion protects federated learning technology driving pharma partnerships, biosecurity initiatives, and precisi...

renovaros-maurice-van-tilburg-resigns-as-chairman-of-the-board-of-directors-effective-august-22-2025
Renovaro's Maurice Van Tilburg Resigns As ...
07/25/2025 21:22:11

-SEC Filing

renovaro-biosciences-announces-publication-of-peer-reviewed-study-in-vaccines-says-preclinical-data-validate-renovaros-platform-representing-step-forward-in-fight-against-pancreatic-and-solid-tumors
Renovaro Biosciences Announces Publication...
07/17/2025 13:20:34

Landmark preclinical data validate Renovaro's platform representing a step forward in the fight against pancreatic and soli...

renovaro-says-senior-debt-holders-agreed-to-convert-97m-of-outstanding-senior-debt-into-convertible-debt-which-they-have-elected-to-convert-to-equity
Renovaro Says Senior Debt Holders Agreed T...
07/09/2025 12:04:19

renovaros-biosymetrics-unveils-proprietary-ai-based-zebrafish-screening-platform-to-identify-medical-countermeasures-for-neurotoxic-chemical-agents
Renovaro's BioSymetrics Unveils Proprietar...
06/30/2025 13:30:58

Renovaro Inc.'s (NASDAQ:RENB) wholly owned subsidiary BioSymetrics has unveiled a proprietary AI-based zebrafish screening ...

renovaro-subsidiary-biosymetrics-secures-uspto-patent-allowance-for-ai--powered-drug-discovery
Renovaro Subsidiary BioSymetrics Secures U...
06/03/2025 13:17:09

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION